BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1844916)

  • 1. [Oncogene expression in malignant head and neck neoplasia].
    Sartoris A; Aluffi P; Montemagno A; Gerbaudo EV; Gariglio M; Cavallo GP
    G Batteriol Virol Immunol; 1991; 84(1-12):25-30. PubMed ID: 1844916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of oncogenes C-myc, C-raf and N-ras in advanced cancers of the upper respiratory and digestive tracts. Correlation with tumor clinical response to chemotherapy].
    Reyt E; Lavieille JP; Brambilla E; Barra Y; Riva C
    Ann Otolaryngol Chir Cervicofac; 1993; 110(6):310-5. PubMed ID: 8210089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple transcriptional activation of cellular oncogenes in human head and neck solid tumours.
    Spandidos DA; Lamothe A; Field JK
    Anticancer Res; 1985; 5(2):221-4. PubMed ID: 2581495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ras mutations and expression in head and neck squamous cell carcinomas.
    Yarbrough WG; Shores C; Witsell DL; Weissler MC; Fidler ME; Gilmer TM
    Laryngoscope; 1994 Nov; 104(11 Pt 1):1337-47. PubMed ID: 7968162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in expression of oncogenes and tumor suppressor genes in different sites of head and neck squamous cell.
    Takes RP; Baatenburg de Jong RJ; Schuuring E; Litvinov SV; Hermans J; Van Krieken JH
    Anticancer Res; 1998; 18(6B):4793-800. PubMed ID: 9891559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drug resistance, oncogenes, and anti-oncogenes in epithelial tumors].
    Riva-Lavieille C
    Bull Cancer; 1994 Dec; 81 Suppl 2():105s-111s. PubMed ID: 7727855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple fractions of gamma rays do not induce overexpression of c-myc or c-Ki-ras oncogenes in human cervical carcinoma cells.
    Osmak M; Sorić J; Matulić M
    Neoplasma; 1993; 40(6):359-62. PubMed ID: 8289968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between successful heterotransplantation of lung tumors in nude mice, poor prognosis of patients and expression of Fos, Jun, ErbB1, and Ras.
    Volm M; Mattern J
    Anticancer Res; 1993; 13(6A):2021-5. PubMed ID: 8297109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent amplification of the bcl-1 locus in head and neck squamous cell carcinomas.
    Berenson JR; Yang J; Mickel RA
    Oncogene; 1989 Sep; 4(9):1111-6. PubMed ID: 2476705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Amplification of the expression of the c-myc oncogene in bronchial epidermoid carcinoma in man].
    Douc-Rasy S; Terrier P; Kemeny JL; Amouroux J; Riou G
    C R Acad Sci III; 1985; 301(13):621-6. PubMed ID: 3937573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of c-myc messenger RNA in primary and metastatic lesions of carcinoma of the stomach.
    Onoda N; Maeda K; Chung YS; Yano Y; Matsui-Yuasa I; Otani S; Sowa M
    J Am Coll Surg; 1996 Jan; 182(1):55-9. PubMed ID: 8542090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Detection of 8 oncogenes in squamous epithelial cancers of the head and neck].
    Jungehülsing M; Volling P
    HNO; 1994 May; 42(5):280-7. PubMed ID: 8050916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Oncogenes in squamous epithelial cancers in the area of the head and neck].
    Volling P; Jungehülsing M; Tesch H; Stennert E
    Laryngol Rhinol Otol (Stuttg); 1988 Apr; 67(4):160-4. PubMed ID: 3386367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas.
    Jares P; Fernández PL; Campo E; Nadal A; Bosch F; Aiza G; Nayach I; Traserra J; Cardesa A
    Cancer Res; 1994 Sep; 54(17):4813-7. PubMed ID: 8062283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amplification of the int-2 gene in human head and neck squamous cell carcinomas.
    Somers KD; Cartwright SL; Schechter GL
    Oncogene; 1990 Jun; 5(6):915-20. PubMed ID: 2193294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low levels of ras p21 oncogene expression correlates with clinical outcome in head and neck squamous cell carcinoma.
    Field JK; Yiagnisis M; Spandidos DA; Gosney JR; Papadimitriou K; Vaughan ED; Stell PM
    Eur J Surg Oncol; 1992 Apr; 18(2):168-76. PubMed ID: 1582509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated expression of the c-myc oncoprotein correlates with poor prognosis in head and neck squamous cell carcinoma.
    Field JK; Spandidos DA; Stell PM; Vaughan ED; Evan GI; Moore JP
    Oncogene; 1989 Dec; 4(12):1463-8. PubMed ID: 2687767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression and amplification of c-myc and c-Ha-ras oncogenes in pleomorphic salivary adenoma.
    Xue H; Situ ZQ; Wang CJ; Wu JZ
    Chin Med J (Engl); 1993 Jan; 106(1):22-5. PubMed ID: 8389270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of cancer testis antigens in head and neck squamous cell carcinomas.
    Figueiredo DL; Mamede RC; Proto-Siqueira R; Neder L; Silva WA; Zago MA
    Head Neck; 2006 Jul; 28(7):614-9. PubMed ID: 16475205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential biomarkers for head and neck squamous cell carcinoma.
    Brown JJ; Xu H; Nishitani J; Mohammed H; Osborne R; Teklehaimanot S; Gill G; Liu X
    Laryngoscope; 2003 Mar; 113(3):393-400. PubMed ID: 12616185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.